Tag: FDA

July 20, 2022
FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

READ MORE
May 18, 2022
FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

READ MORE
May 15, 2022
FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.

READ MORE
February 21, 2022
FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

READ MORE
December 20, 2021
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

READ MORE
September 24, 2021
FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

READ MORE
August 5, 2021
New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

READ MORE
July 5, 2021
FDA and CDC: Vaccinated Adults Will Not Need COVID-19 Booster Shots

A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.

READ MORE
June 6, 2021
FDA Approves First New Weight Loss Drug Since 2014, Issues EUA for COVID-19 Antibody

Wegovy (semaglutide) and sotrovimab will soon be available.

READ MORE
May 31, 2021
FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.

READ MORE
1 2 3 6
lockenvelopephone-handsetmenucross-circle